Bangladesh DGHS 2017: malaria treatment regimen (6th version)
Bangladesh national DGHS Bangladesh Current
Revised Malaria Treatment Regimen 2017 (6th version)
National Malaria Elimination & Aedes Transmitted Diseases Control Program, CDC, DGHS, Bangladesh. Printed January 2019
Summary checked against the source: 2026-11
Distributed by the National Malaria Elimination Program, DGHS; see the local PDF Malaria_BD-DGHS_2017_Revised-Treatment-Regimen.pdf
The Revised Malaria Treatment Regimen 2017 (6th version, printed January 2019) from the National Malaria Elimination & Aedes Transmitted Diseases Control Program. Page numbers are the booklet's printed pages.
At a glance
- Treat only confirmed malaria: diagnose by RDT or blood slide examination (BSE); symptom-based diagnosis is unreliable. [p. 4]
- Uncomplicated falciparum: artemether–lumefantrine, 6 doses over 3 days, plus primaquine 0.25 mg/kg single dose on day 1. [p. 7, 11]
- Severe malaria: IV artesunate 2.4 mg/kg at 0, 12 and 24 h, then daily; then a full oral ACT course. [p. 13, 21]
- Vivax: chloroquine 3 days + primaquine 0.25 mg/kg for 14 days. [p. 15]
- Mixed infection: ACT 3 days + primaquine 14 days. [p. 15]
- Pregnancy: ACT in all trimesters (2017 change); no primaquine in pregnancy or while breastfeeding up to 6 months. [p. 3, 16]
Case definitions
| Type | Definition |
|---|---|
| Uncomplicated falciparum | Fever within 48 h, no other convincing cause, no severe features, high suspicion (jhum cultivator, forest goer, new arrival, travel to an endemic area), and P. falciparum on BSE or RDT |
| Severe malaria | Fever within 48 h + ≥1 clinical or laboratory feature of severity + asexual P. falciparum on BSE or RDT |
| Vivax | As above with P. vivax on BSE or RDT |
| Mixed | Common in Bangladesh; BSE is better than RDT (several RDTs miss mixed infection) |
Adapted from BD-DGHS 2017 case definitions [p. 4–6]
Features of severe malaria
| Clinical | Laboratory |
|---|---|
| Altered behaviour, confusion, drowsiness, coma (cerebral malaria) | Acidosis: base deficit >8, bicarbonate <15 mmol/L or lactate ≥5 mmol/L |
| >2 convulsions in 24 h | Hypoglycaemia <2.2 mmol/L (40 mg/dL) |
| Pulmonary oedema (RR >30) or ARDS, acidotic breathing | Severe anaemia: Hb ≤5 g/dL (children <12) or <7 g/dL (adults), with parasites >10,000/µL |
| Shock: SBP <80 mm Hg adults (<70 children) with poor perfusion ("algid malaria") | Renal impairment: creatinine >265 µmol/L (3 mg/dL) or urea >20 mmol/L |
| Clinical jaundice | Bilirubin >50 µmol/L (3 mg/dL) with parasites >100,000/µL |
| Prostration; vomiting everything; abnormal bleeding | Pulmonary oedema on X-ray or SpO₂ <92% |
| Oliguria (<400 mL/24 h) | Hyperparasitaemia >10% |
Adapted from BD-DGHS 2017 [p. 5–6]
RDT pitfalls: it can stay positive after antimalarial treatment in the last 4 weeks, and very low parasite counts can be missed. [p. 6]
Diagnosis and management chart
flowchart TD
A["Fever or history of fever with high suspicion of malaria<br/>(jhum cultivators, forest goers, new arrivals,<br/>travel to endemic area, short-term travellers)"] --> B["BSE or RDT"]
B --> PF["Positive for falciparum"]
B --> PV["Positive for vivax"]
B --> NEG["Negative"]
PF --> SEV{"Any feature of severity?<br/>unconscious, convulsion, prostration,<br/>jaundice, severe anaemia, acidosis, ARDS"}
SEV -->|Yes| SM["Severe malaria → Treatment B<br/>IV artesunate (or IM artemether)<br/>or IV/IM quinine, then oral ACT<br/>+ primaquine 0.25 mg/kg single dose"]
SEV -->|No| UM["Uncomplicated → Treatment A<br/>ACT 6 doses (24 tablets, adult)<br/>or quinine 7 days + tetracycline / doxycycline /<br/>clindamycin 7 days<br/>+ primaquine 0.25 mg/kg single dose"]
PF -.->|"Mixed"| MX["Treatment D<br/>ACT 6 doses (or Q7 + T/D/C7)<br/>+ primaquine 0.25 mg/kg × 14 days"]
PV --> VM["Treatment C<br/>chloroquine 3 days<br/>+ primaquine 0.25 mg/kg × 14 days"]
NEG --> N["Diagnose clinically and record; treat accordingly<br/>Repeat BSE/RDT if suspicion is very high<br/>Very sick and no test available: start parenteral treatment"]
Adapted from BD-DGHS 2017 Malaria diagnosis and management chart [p. 19]
Uncomplicated falciparum (Treatment A)
| Dose | Hour | 5–<15 kg | 15–<25 kg | 25–<35 kg | ≥35 kg |
|---|---|---|---|---|---|
| 1 | 0 | 1 | 2 | 3 | 4 |
| 2 | 8 | 1 | 2 | 3 | 4 |
| 3 | 24 | 1 | 2 | 3 | 4 |
| 4 | 36 | 1 | 2 | 3 | 4 |
| 5 | 48 | 1 | 2 | 3 | 4 |
| 6 | 60 | 1 | 2 | 3 | 4 |
Artemether 20 mg + lumefantrine 120 mg tablets. Second dose at 8 h, then 12-hourly to 6 doses (adult: 4 tablets each, 24 tablets). Take with fatty food or milk: fat improves lumefantrine absorption. Adapted from BD-DGHS 2017 first-line treatment table [p. 7–8]
Alternatives if artemether–lumefantrine can't be given:
| Regimen | Dose |
|---|---|
| Artesunate + amodiaquine (daily × 3 days) | 4.5–<9 kg: 25 + 67.5 mg; 9–<18: 50 + 135; 18–<36: 100 + 270; ≥36: 200 + 540 mg. Avoid with efavirenz or zidovudine (neutropenia, hepatotoxicity) |
| Artesunate + mefloquine (daily × 3 days) | Artesunate 4 mg/kg + mefloquine 8.3 mg/kg; nausea, dizziness, dysphoria, sleep disturbance |
| Dihydroartemisinin + piperaquine (daily × 3 days) | By weight, e.g. 60–<80 kg: 160 + 1280 mg |
| Quinine 7 days + tetracycline, doxycycline or clindamycin 7 days (Q7+T7/D7/C7) | Quinine 10 mg/kg 8-hourly; tetracycline 250 mg 6-hourly; doxycycline 100 mg daily; clindamycin 10 mg/kg twice daily. No tetracycline or doxycycline under 8 years, in pregnancy or lactation |
Adapted from BD-DGHS 2017 [p. 8–11, 20]
- Failure of one regimen: after ACT, use Q7+T/D/C7; after Q7+T/D/C7, use ACT. [p. 11]
- Primaquine 0.25 mg/kg single dose on day 1 to block transmission; not in pregnancy, infants <6 months or breastfeeding mothers up to 6 months. [p. 11]
- Infants <5 kg: ACT at the same mg/kg target dose. Hyperparasitaemia 4–10%: first ACT dose then admit. Returning travellers: ACT. [p. 12]
Severe malaria (Treatment B)
Parenteral treatment [p. 13–14, 21]
- IV artesunate is the drug of choice: 2.4 mg/kg at 0, 12 and 24 h, then daily until oral treatment is possible (max 5 days; at least 3 doses or 24 h). Children <20 kg: 3 mg/kg. No dose change for renal or hepatic failure.
- If not possible: IM artesunate, or IM artemether 3.2 mg/kg stat then 1.6 mg/kg daily.
- If no artemisinin: quinine dihydrochloride 20 mg salt/kg loading over 4 h in 5% dextrose (or IM split into both anterior thighs), then 10 mg/kg 8-hourly; reduce to 15–20 mg/kg/day after 6 doses.
- Follow on with a full ACT course (6 doses) once the patient can swallow; otherwise oral quinine + tetracycline, doxycycline or clindamycin to complete 7 days.
Pre-referral treatment saves lives: artesunate suppository 10 mg/kg under 6 years; IM artesunate, artemether or quinine (20 mg/kg, half in each thigh) above 6 years; then hospital. [p. 14]
Vivax and mixed infection
| Drug | Dose |
|---|---|
| Chloroquine (150 mg base tablet) | 10 mg/kg day 1, 10 mg/kg day 2, 5 mg/kg day 3 (adult 4, 4, 2 tablets) |
| Primaquine | 0.25 mg/kg daily for 14 days, starting on day 1 with chloroquine |
| Mixed infection | ACT 6 doses + primaquine 0.25 mg/kg for 14 days (or Q7+T/D/C7 if ACT unavailable) |
Adapted from BD-DGHS 2017 Treatments C and D [p. 15, 22]
Primaquine and G6PD deficiency [p. 15]
G6PD-deficient patients can develop severe haemolysis (anaemia, jaundice, dark urine, haemoglobinuria). Stop primaquine and admit for transfusion and support. Follow up everyone on the 14-day course.
Pregnancy
| Treatment | |
|---|---|
| Uncomplicated falciparum | ACT in all trimesters; alternative Q7 + C7 |
| Severe malaria | IV artesunate (or IM artemether) in all trimesters; quinine if no artemisinin; then oral ACT |
| Vivax | Chloroquine 3 days, safe in all trimesters; repeat for each relapse |
| Primaquine | Contraindicated in pregnancy and lactation up to 6 months; give radical cure after that |
Adapted from BD-DGHS 2017 [p. 16]
Prevention and drugs not to use
- Chemoprophylaxis is discouraged (multi-drug-resistant area); use bed nets and repellents, and test every fever within 4 weeks of a visit. If needed, mefloquine 250 mg weekly, from 2 weeks before to 4 weeks after the visit. [p. 17]
- Don't use: chloroquine for falciparum (high failure), sulfadoxine–pyrimethamine (high failure), or any monotherapy (quinine, mefloquine, artesunate), which encourages resistance. [p. 17]
Clinical pearls
- Artemether–lumefantrine at 0, 8, 24, 36, 48, 60 h with fatty food; adult 4 tablets per dose.
- Primaquine: 0.25 mg/kg once for falciparum (transmission), 14 days for vivax (relapse); check G6PD, avoid in pregnancy.
- Severe malaria: IV artesunate 2.4 mg/kg at 0, 12, 24 h; watch for hypoglycaemia (worse with quinine).
- Cerebral malaria = unrousable coma; algid malaria = shock.
Classes and levels of evidence
DGHS 2017 treatment regimen is a national programme guideline. It gives standard regimens and operational instructions without grading them by class or level of evidence, so citations on this page give only the page number in the original document. Where it follows WHO guidance, the strength of the WHO recommendation isn't restated.